CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Continue reading

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Continue reading

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Continue reading

Advertisement

CPHI Milan
DDL 2026

Advertisement

Merxin March 2026

Advertisement

Lifecore Biomedical

Advertisement

Solstice

Advertisement

Nipro April 2026
Volume 14 Issue 4

Brexit – Impact, Challenges, and Solutions for The Pharmaceutical Industry

Brexit has provided several challenges to the pharmaceutical industry that required robust actions and swift resolution in order to remain in compliance following th...
Continue Reading →
News

New report sheds light on medicine shortages in Northern Ireland following Brexit

Informa Pharma Intelligence (IPI) has found that some drug firms may withdraw up to 90% of their products from Northern Ireland, once the Brexit grace period has pas...
Continue Reading →
News

Brexit rare disease warning from Cambridge dad hoping to cure sons

A Cambridge dad hoping to find a cure for a devastating condition which affects his two boys has warned of the potential consequences of Brexit on rare disease resea...
Continue Reading →
News

Immigration must be flexible to allow employers to recruit skills, says Cavendish Coalition

          Responding to the Migration Advisory Committee (MAC) interim update on European Economic Area workers in the UK, Cavendish Co...
Continue Reading →
News

LORDS URGE GOVERNMENT FOR CLARITY ON EU HEALTHCARE DEAL

The House of Lords EU Committee has today published its report Brexit: reciprocal healthcare. The Committee warns that in the absence of an agreement on reciprocal h...
Continue Reading →
News

With UK Pharma facing Brexit headwinds, could UK Gov't defeat help industry by leading to a “softer” Brexit? asks GlobalData

The UK Government’s narrow defeat (Wednesday 13th November) on amendment seven of the European Union withdrawal bill, demanding that Parliament have a binding vote ...
Continue Reading →
News

Focus should be on public health and patient safety after EMA relocation decision, says Brexit Health Alliance

Responding to the announcement about the new location of the European Medicines Agency (EMA), Niall Dickson, co-chair of the Brexit Health Alliance, said: “The ...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Tjoapack
Aptar – 08/01/2026